Molnupiravir a nice tool in the tool box for stage 1 COVID-19. Problem is in stage 2 , the non replication stage day 10 ( virus is not replicating) is the most dangerous and destructive stage. The attack is directed at the alveolar 2 . Only therapeutic that has shown efficacy at this stage is Zyesami. $ nrxp. Let’s go FDA !! Continue to be optimistic about MRK! 😃 $Merck(MRK)$
精彩评论